Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 1,801 shares at $20.09 ($36K) on 2024-03-06, disclosed to the SEC on 2024-03-08.
Scheduled sale ($36k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.09 | 1,733 | $35K | 96.2% |
| 2 | $20.00 | 68 | $1K | 3.8% |
| Total | $20.09 avg | 1,801 | $36K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |